India positions CDRI as a key Global Platform for Climate-resilient Infrastructure (See 'Corp Brief') ICAR-NIHSAD Develops Indigenous H5N1 Vaccine to Strengthen Poultry Disease Control (See 'Corp Brief') ICMR marks 115 years of service to the nation; 17 indigenous health technologies showcased (See 'Corp Brief') IEPFA and SEBI Organise 'Niveshak Shivir' in New Delhi (See 'Corp Brief') Letters of Intent for land allotment to be distributed to prospective investors (See 'Corp Brief') President Murmu inaugurates Golden Jubilee celebrations of ICMR-National Institute of Malaria Research (See 'Corp Brief') Tribal communities have been guardians of biodiversity: MoS (See 'Corp Brief') NITI Aayog holds first National Workshop on 'Leadership as a Mission' (See 'Corp Brief') MISC - Resolution Plan has been approved under the IBC - No further adjudication is required in the present writ petition: HC (See 'Legal Desk') IEPFA and SEBI to Organize 'Niveshak Shivir' in New Delhi (See 'Corp Brief') Ministry of Power Pavilion showcases Power Sector Initiatives at IIFT (See 'Corp Brief') MY Bharat mobilises over 81,600 youth and citizens through Sports Meets (See 'Corp Brief') 12th Session of India-Belarus Inter-Governmental Commission held in New Delhi (See 'Corp Brief') CPC/Limitation - Entries in books of account & balance sheets can constitute acknowledgment of liability u/s 18 of Limitation Act, provided they indicate subsisting jural relationship when read with surrounding circumstances: SC LB (See 'Legal Desk') India to host Ministerial Meeting of International Coconut Community in Kochi (See 'Corp Brief') India Post releases Commemorative Postage Stamp on Pioneer of Biogas Technology (See 'Corp Brief') NICDC Pavilion showcases AP's Greenfield Industrial Smart Cities (See 'Corp Brief') CCPA imposes Penalty of Rs 20 Lakh on ExportersIndia.com (See 'Corp Brief') IBC - RP required to function independently & cannot act according to whims & fancies of a dominant Financial Creditor - CoC's majority decision to replace RP cannot be interfered with by another Financial Creditor holding minority voting share: NCLAT (See 'Legal Desk') IITF 2026 - EPFO Lounge & ESIC Pavilion inaugurated (See 'Corp Brief') Giriraj Singh visits Welspun World's State-of-the-Art Manufacturing Units in Kutch (See 'Corp Brief') PMLA - Status of secured creditor & initiation of prior recovery proceedings under SARFAESI Act do not exempt a property from attachment under PMLA, when property constitutes proceeds of crime: SAFEMA Tribunal (See 'Legal Desk') Indian Business leaders and Start ups to participate in the India-Egypt Business Forum (See 'Corp Brief') NRIDA selected for Medal for Innovation in Road Technology (See 'Corp Brief') PMLA - Objectives of special anti-money laundering law supersede private commercial security interests - properties linked to criminal activities liable to provisional & final attachment: SAFEMA Tribunal (See 'Legal Desk') Shilp Samagam Mela 2026 at Dilli Haat records Cumulative Sales of Over Rs 88.36 Lakh (See 'Corp Brief') National Tribal Literary Festival concludes with Emphasis on Preserving Oral Traditions (See 'Corp Brief') SEBI - Freezing the Appellants' demat & bank accounts pending deposit of alleged unlawful gains of Rs. 28.12 crore, is valid: SAT (See 'Legal Desk') An unsuccessful 'success fee' litigation (See CORP EINSICHT)

ICAR-NIHSAD Develops Indigenous H5N1 Vaccine to Strengthen Poultry Disease Control

Published: Nov 19, 2026

By TIOLCorplaws News Service

NEW DELHI, NOV 19, 2026: THE Union Minister of Agriculture and Farmers Welfare and Rural Development, Shivraj Singh Chouhan, will dedicate India's first indigenous Inactivated H5N1 (Clade 2.3.2.1a) Highly Pathogenic Avian Influenza (HPAI) Vaccine for Chickens to the Nation on 20 th November, 2026 at ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal. Developed indigenously by ICAR-NIHSAD, Bhopal, the vaccine is the first of its kind in India against the H5N1 HPAI virus of Clade 2.3.2.1a.

Highly Pathogenic Avian Influenza (HPAI), commonly known as bird flu, is a serious disease affecting poultry. Outbreaks can cause nearly 100 per cent mortality among infected birds, leading to major financial losses for poultry farmers due to the large-scale culling of birds and restrictions on trade. The impact is not limited to poultry farms; it can also affect global trade, prices of poultry products and the livelihoods of farmers. Since the first detection of the disease in India in 2006, more than 500 combined outbreaks of H5N1 and H5N8 subtypes have been reported in the country.

A major outbreak of bird flu could reduce India's GDP growth by up to 1.5 per cent, while more than 20 per cent of the country's poultry population could be at risk if the disease spreads without control. The 2006 bird flu outbreak caused estimated direct and indirect losses of Rs. 2,200-3,000 crore. An outbreak in Manipur also resulted in losses equivalent to 0.5 per cent of the state's GDP. The disease is also a public health concern. According to the World Health Organization (WHO), 1,003 human cases of H5N1 avian influenza, including 479 deaths, have been reported across 25 countries, including India, since 2003.

Studies of the virus have shown that the H5N1 strain known as Clade 2.3.2.1a has been responsible for most bird flu outbreaks in chickens. In recent times, infections caused by this strain have also been detected in different animal species, including mammals, along with three human cases. This makes it important to control the spread of this virus to reduce financial losses for poultry farmers and prevent its transmission from chickens to other animals and humans.

At present, no specific commercial vaccine is available against the H5N1 virus of Clade 2.3.2.1a. Therefore, developing an indigenous vaccine is important for India. The vaccine developed by ICAR-NIHSAD aims to address this need by providing protection against Clade 2.3.2.1a H5N1 virus strains circulating in the country.

TIOL CORP SEARCH

TIOL GROUP WEBSITES